Vera Therapeutics Inc (NASDAQ: VERA) is -0.24% lower on its value in year-to-date trading and has touched a low of $14.20 and a high of $51.61 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VERA stock was last observed hovering at around $42.10 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $42.19, the stock is -1.98% and -7.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.4 million and changing 0.21% at the moment leaves the stock 3.62% off its SMA200. VERA registered 132.71% gain for a year compared to 6-month gain of 15.46%. The firm has a 50-day simple moving average (SMA 50) of $45.446 and a 200-day simple moving average (SMA200) of $40.709.
The stock witnessed a -12.94% loss in the last 1 month and extending the period to 3 months gives it a 9.19%, and is -0.24% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.45% over the week and 4.64% over the month.
Vera Therapeutics Inc (VERA) has around 51 employees, a market worth around $2.67B and $0.00M in sales. Distance from 52-week low is 197.11% and -18.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-39.28%).
The EPS is expected to shrink by -25.62% this year
262.0 institutions hold shares in Vera Therapeutics Inc (VERA), with institutional investors hold 101.67% of the company’s shares. The shares outstanding are 55.03M, and float is at 48.99M with Short Float at 13.88%. Institutions hold 94.67% of the Float.
The top institutional shareholder in the company is AVORO CAPITAL ADVISORS LLC with over 4.31 million shares valued at $155.92 million. The investor’s holdings represent 8.4548 of the VERA Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 3.62 million shares valued at $130.98 million to account for 7.1022 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.34 million shares representing 6.5481 and valued at over $120.76 million, while FMR LLC holds 5.497 of the shares totaling 2.8 million with a market value of $101.37 million.
Vera Therapeutics Inc (VERA) Insider Activity
Vera Therapeutics Inc disclosed in a document filed with the SEC on Dec 18 ’24 that Fordyce Marshall (PRESIDENT AND CEO) sold a total of 17,500 shares of the company’s common stock. The trade occurred on Dec 18 ’24 and was made at $43.07 per share for $0.75 million. Following the transaction, the insider now directly holds 85942.0 shares of the VERA stock.
Still, SEC filings show that on Dec 18 ’24, MARSHALL FORDYCE (Director) Proposed Sale 17,500 shares at an average price of $43.91 for $0.77 million. The insider now directly holds shares of Vera Therapeutics Inc (VERA).
